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Introduction: The number of patients who could beneﬁt from liver transplantation markedly exceeds the
number of available donors. This increasing gap has fuelled efforts to maximize existing donor pool and
identify new avenues.
Aims and objectives: To compare the outcome in deceased donor liver transplant (DDLT) based on
extended donor selection criteria.
Materials and methods: Donor and recipients' data were analyzed following DDLT from Mar 2007 to Feb
2013. Donors were grouped into either ideal donor (ID) or extended criteria donor (ECD) based on donor
and graft related characteristics. Primary nonfunction (PNF) and patient survival were the primary
endpoints while early graft dysfunction (EGD) and incidence of major postoperative complications were
the secondary endpoints of the study.
Results: We had a total of 6 mortalities (13%) at the end of 1 year. The Kaplan Meier survival analysis at 7
days, 3, 6 and 12 months were not statistically different (p > 0.05). PNF occurred in three (6.5%) patients
and was not signiﬁcantly different nor inﬂuenced by cumulative number of risk factors in the subgroup
analysis (p < 0.3). However, the incidence of EGD was signiﬁcantly inﬂuenced by the cumulative number
of risk factors (p < 0.005). A total of 12 (26.1%) patients were graded with 3 or more complications ac-
cording to the 'Clavien Dindo Grade' for major post operative complications, although it did not reach a
statistical signiﬁcance in the various subgroups. Univariate analysis of the donor risk factors showed that
none of these factors were predictive for PNF and mortality in deceased donor liver transplant recipients.
Conclusion: Although the incidence of early graft dysfunction is statistically more with increase in
number of donor risk factors, the overall survival and outcome in extended criteria liver donors are
similar to that of an ideal donor. With the supply demand gap widening, extended criteria for selection of
deceased donors will deﬁnitely expand the donor pool without adversely affecting the outcome of liver
transplantation.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.h).
by Elsevier Ltd. All rights reserved1. Introduction
Liver transplantation (LT) has been the only proven treatment
for patients with end-stage liver disease or hepatocellular carci-
noma in cirrhotic patients. With the widening indications, the de-
mand for organs has been increasing steadily and exceeds the.
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population and scarcity of brain stem deaths has made living donor
liver transplantation the more common mode of transplantation in
India. However, unlike India and other Asian countries most
transplant centres in the world still depend on the deceased donor
pool as opposed to live donation. One of the main strategies to
address this discrepancy is expansion of the Deceased Donor pool
utilizing extended criteria donor (ECD) [1e3].
2. Aims and objectives
Till date we have one of the largest number of deceased donor
liver transplantation (DDLT) in India. We wanted to compare the
outcome in DDLT based on extended donor selection criteria. Pri-
mary non function (PNF) and patient survival were the primary
endpoints while early graft dysfunction (EGD) and incidence of
major postoperative complications were the secondary endpoints
of the study.
3. Materials and methods
We analyzed donors and recipients’ data following DDLT from
Mar 2007 to Feb 2013 at our Transplant Centre. All donor and
recipient data were stored in Access software, Windows Ofﬁce
2007. All donors were grouped into either ideal donor (ID) or
extended criteria donor (ECD) based on certain donor and graft
related characteristics.
An ECD was deﬁned as follows: (1) age > 60 years; (2) macro-
vesicular steatosis >30%; (3) prolonged intensive care unit (ICU)
stay (>4 days); (4) hemodynamic risk factors (any two of the
following): prolonged hypotension (systolic blood pressure
<60 mm Hg for more than 2 h), use of dopamine > 10 mcg/kg/
minute for more than 6 h to sustain blood pressure, and need for 2
inotropic drugs to sustain donor blood pressure for more than 6 h;
(5) Deranged liver function test (any two of the following): Serum
bilirubin > 2 mg/dl, AST > 170 IU/L, ALT > 140 IU/L; (6) Increased
Total Leucocytes Count (TLC) > 12,000/cumm; (7) cold ischemic
time > 12 h; and (8) hypernatremia (Na peak > 155 mEq/L) before
aortic cross clamp.
On presence of cumulative number of risk factors, these patients
were further divided into 3 subgroups: the ID group receiving an
ideal graft, the ECD1 group receiving a graft with 1 or 2 risk factors,
and the ECD2 group receiving a graft with 3e4 risk factors. The
donormanagement, retrieval, recipient evaluation, transplantation,
and management were as per the protocol followed by our centre.
3.1. Exclusion criteria
As per our institutional policy, we rejected grafts from patients
with a history of malignancy, grossly fatty liver on inspection,
cirrhotic liver, serum sodium >170 mEq/L, and those donors not
showing decreasing trend with sodium-free ﬂuid, TLC >15,000/
cumm, liver enzyme level >600 U/L, and serum bilirubin >4 mg%.
3.2. Assessment of outcomes
Outcome parameters were assessed daily with serum peaks of
ALT and AST, serum bilirubin, INR, hepatic encephalopathy, bil-
iovascular complications, and patient survival at 1 week, 1, 3 and 6
months and at 1 year after transplantation. EGD was deﬁned as
presence of at least one of the following e serum bilirubin >10 mg/
dL on postoperative day 7, INR 1.6 on postoperative day 7, and ALT
or AST > 2000 IU/mL within the ﬁrst 7 days [4]. PNF was deﬁned as
non life-sustaining function of the liver requiring retransplantation
or leading to death within 7 days after liver transplantation [5]. Theimmunosuppression consists of tacrolimus, MMF, and corticoste-
roids. The patients were weaned off corticosteroids within 3
months, except in cases of transplantation due to autoimmune
hepatitis which were treated with corticosteroid continuously.
4. Statistical analysis
Data are expressed as means ± standard deviation for contin-
uous variables and as percentages for categorical variables wher-
ever applicable. Other variables were expressed as medians. Data
was compared with the 2-tailed chi-square test or Fisher's exact
test for categorical variables and with the Student t test; analysis of
variance and the median test were used for continuous variables. P
values <0.05 were considered signiﬁcant. Multivariate analysis of
variables currently listed to deﬁne an ECD was used to assess the
impact on recipient survival. Survival analysis was performed with
the KaplaneMeier method; the log rank test was used to test for
statistically signiﬁcant observed differences. All statistical analysis
was performed using Stata 9.0 (College Station, Texas, USA).
5. Results
Between Mar 2007 and Feb 2013, of 122 brain deaths, 99 po-
tential donors were counseled for organ donation by the coun-
sellor, of which 49 consented for liver donation. Three cases were
rejected during the organ procurement process, one due to
cirrhosis on gross examination and the other two due to massive
colonic and small bowel gangrene. 46 brain deaths underwent
multiorgan retrieval. Of 46 grafts, 6 were subjected to intra
operative biopsy on visual inspection of the liver and was found to
have signiﬁcant steatosis (>30%). There were 35 (76.1%) ECD grafts
and 11 (23.9%) ID grafts. The ECD graft group was further sub-
divided into 2 subgroups: ECD1 with 23 (50%) patients and ECD2
with 12 (26.1%) patients. All the subgroups were well matched
with respect to age, sex and indication of liver transplantation,
Child Pugh Turcott Score (CTP), model for end-stage liver disease
(MELD), warm ischemia time (WIT), blood loss and mean opera-
tive time (Table 1). There were 6 mortalities (13%) at the end of 1
year. The Kaplan Meier survival analysis in various subgroups at 7
days, 3, 6 and 12 months were not signiﬁcantly different (p < 0.07)
(Fig. 1). PNF occurred in 3 (6.5%) patients and was not signiﬁcantly
different nor inﬂuenced by cumulative number of risk factors on
subgroup analysis (p < 0.3). The incidence of EGD was signiﬁcantly
inﬂuenced by the cumulative number of risk factors (p < 0.005)
(Table 2). Although 12 (26.1%) patients were graded with 3 or
more complications according to the ‘Clavien Dindo Grade’ for
major postoperative complications, it did not reach a signiﬁcant
signiﬁcance among the various subgroups. Univariate analysis of
the donor risk factors showed that none of these factors were
predictive for PNF and mortality in deceased donor liver transplant
recipient (Table 3).
6. Discussion
ECD grafts are being increasingly accepted due to the growing
demand for deceased donor grafts. However, there is a lack of
consensus on the deﬁnition of an ECD graft and the factors that
should exclude a graft from use because of increased risk to the
recipient. The use of ECD liver grafts has been debated for decades
[6]. Several reports have failed to unify the criteria for ECD liver
grafts that can be universally accepted [7]. The most important
message from this body of literature is the acceptance of the
increased risk of failure as determined by the use of ECD liver grafts.
Although, on the positive side, their use will also expand the donor
pool. Critical in this regard is the adoption of a policy of detailed
Table 1
Demographic and clinical data of the recipients in the subgroups.
Characteristics ID group (11) ECD1 group (23) ECD2 group (12) P Value
Number Mean ± SD or % Number Mean ± SD or % Number Mean ± SD or %
Age (years) 11 39.3 ± 15.7 23 50.3 ± 19.1 12 40.3 ± 19.8 0.74
Sex
Male 8 30.8% 13 50.0% 5 19.2% 0.37
Female 3 15.0% 10 50.0% 7 35.0%
CTP Score 11 10.4 ± 1.3 23 9.9 ± 1.6 12 11.1 ± 1.9 0.62
9 4 23.5% 10 58.8% 3 17.7%
>9 7 24.2% 13 44.8% 9 31.0%
MELD Score 11 18.5 ± 2.8 23 18.7 ± 2.4 12 18.7 ± 1.7 0.34
18 5 35.7% 5 35.7% 4 28.6%
>18 6 18.8% 18 56.3% 8 24.9%
Etiology
HBV 2 25.0% 3 37.5% 3 37.5% 0.17
HCV 2 22.2% 5 55.6% 2 22.2% 0.08
Alcoholic 1 25.0% 2 50.0% 1 25.0% 0.08
Budd Chiari 1 25.0% 3 75.0% nil 0% 0.06
Cryptogenic 3 23.0% 6 46.2% 4 30.8% 0.47
Autoimmune 2 25.0% 4 50.0% 2 25.0% 0.08
Operative parameters
WIT, (min) 11 35.9 ± 4.4 23 34.5 ± 5.1 12 34.8 ± 5.5 0.78
Operative time, (mins) 11 656.4 ± 78.1 23 663.5 ± 75.6 12 680.8 ± 67.9 0.89
Blood loss, (ml) 11 447.3 ± 125.5 23 454.3 ± 94.4 12 450.8 ± 75.4 0.26
Fig. 1. Kaplan Meier estimate in between various subgroups.
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use of that speciﬁc ECD graft and the risk generated by not using
that graft for the speciﬁc clinical condition of the recipient. The
decision to use a speciﬁc organ therefore depends on the centre's
protocol, judgment of the transplant surgeon, and speciﬁc needs of
the recipient. Numerous single-centre reports have identiﬁedTable 2
Postoperative complications in the various subgroups.
Variables ID group, (%) ECD 1 group,
(%)
ECD 2 group,
(%)
P Value
PNF 0 (0%) 1 (4.3%) 2 (16.7%) 0.30
EGD 3 (25.0%) 2 (16.7%) 7 (58.3%) 0.005
Hepatic artery thrombosis 0 (0%) 1 (25.0%) 2 (75.0%) 0.11
Biliary complications 2 (28.6%) 2 (28.6%) 3 (42.8%) 0.42
Portal vein thrombosis 0 (0%) 0 (0%) 1 (100%) 0.50
Hepatic vein outﬂow
tract obstruction
0 (0%) 0 (0%) 0 (0%) e
Clavien Dindo Grade
(III and above)
2 (16.7%) 4 (33.3%) 6(50.0%) 0.11
Mortality 0 (0%) 2 (33.3%) 4 (66.7%) 0.07predictors of potentially poor graft function. Feng et al., [8]
analyzed 20,000 transplants from the Scientiﬁc Registry of Trans-
plant Recipients (SRTR) database and developed a DRI, which is
calculated from seven donor and two transplant variables that were
found to be independently associatedwith an increased risk of graft
failure. These included donor >40 years, donor height, donation
after cardiac death, split/partial grafts, cerebrovascular accident or
other cause of death (except trauma, stroke, or anoxia), cold
ischemia time, and organ sharing outside the local donor service
area. Similarly, Rana et al., [9] identiﬁed 13 recipient factors, 4
donor factors, and 2 operative factors (warm and cold ischemia
times) as signiﬁcant predictors of recipient mortality 3 months
after transplantation, using MELD era data and including retrans-
plants. “Graft malfunction,” which is multifactorial in etiology, has
varying degrees; the severest is the irreversible state of PNF, with
less severe forms exhibiting reversible graft dysfunction termed as
EGD. PNF is the most serious end result of initial poor allograft
function and may occur in 1.4%e8.5% of cases after orthotopic liver
transplantation and requires urgent retransplantation to avoid
patient mortality [5,10e13].
The conditions of the donor, recipient, and surgery inﬂuence
early function of the transplanted liver. This study focused on the
identiﬁcation of the effect of extended criteria donor on outcomes.
Use of extended criteria donors, especially aged donors, has
become more frequent recently. In Europe, donors over 60 years
have increased from less than 5% in the early 1990s toTable 3
Univariate analysis of donor and recipient factors causing PNF and mortality in re-
cipients of ECD grafts.
Criteria Number of
donors (35)
PNF (3) P Value Mortality (5) P Value
Age >60 y 8 1 0.44 1 0.77
Steatosis >30% 6 1 0.35 2 0.17
ICU stay > 4 days 16 2 0.27 4 0.16
Hemodynamic factors 27 3 0.26 5 0.38
Deranged LFT 14 2 0.22 3 0.35
TLC >12,000/cumm 9 1 0.49 2 0.58
Sodium >155 meq/L 6 1 0.35 2 0.17
CIT > 12 h e e e e e
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Registry [14].
The drawback of this study is the small number of patients in
the study groups. This small sample size is likely to result in a type
2 statistical error. On the basis of our data, the primary endpoints,
PNF and patient survival were not signiﬁcantly different, although
there was a trend towards statistical signiﬁcance. The small
number of subjects is a major limitation in the present study.
However, it is evident that EGD is inﬂuenced by cumulative risk
factors in the ECD pool. The analysis of risk factors in the donors
did not play a role in the adverse outcome of the transplant. Our
experience suggests that a change in donor selection criteria,
namely, a more aggressive acceptance of ECDs, did not negatively
inﬂuence the overall outcome. It is critical to realize that there are
no golden rules for identifying the best donor-recipient match,
although there seems to be an overall beneﬁt in accepting ECD
liver grafts. Not accepting a donor liver from a marginal donor may
result in the death of a patient requiring an urgent transplantation
as another donor liver may not become available immediately.
Marginal grafts should be transplanted in recipients with low risk,
i.e. a low model for MELD score and fewer comorbidities. These
grafts perform better in patients who can tolerate a bigger insult
immediately following transplantation when compared with high-
risk recipients. Patient and graft survival have been found to be
signiﬁcantly lower when marginal grafts were used in high-risk
recipients [3,15,16].7. Conclusion
With a small sample size it would be difﬁcult to draw deﬁnite
conclusion from the present study. However, the incidence of early
graft dysfunction was signiﬁcantly more with increase in number
of donor risk factors in this study. The overall survival and
outcome in extended criteria liver donors were similar to that of
an ideal donor. So with the supply demand gap widening,
extended criteria deceased donors if carefully selected would
expand the donor pool without adversely affecting the outcome of
liver transplantation.Ethical approval
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